These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

156 related items for PubMed ID: 498151

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Disposition and distribution of platinum following parenteral administration of cis-dichlorodiammineplatinum(II) to animals.
    Litterst CL, LeRoy AF, Guarino AM.
    Cancer Treat Rep; 1979; 63(9-10):1485-92. PubMed ID: 498147
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Plasma levels and urinary excretion of filterable platinum species following bolus injection and iv infusion of cis-dichlorodiammineplatinum(II) in man.
    Patton TF, Himmelstein KJ, Belt R, Bannister SJ, Sternson LA, Repta AJ.
    Cancer Treat Rep; 1978 Sep; 62(9):1359-62. PubMed ID: 688279
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Effect of a forced diuresis on the distribution and excretion (via urine and bile) of 195mplatinum when given as 195mplatinum cis-dichlorodiammineplatinum(II).
    DeSimone PA, Yancey RS, Coupal JJ, Butts JD, Hoeschel JD.
    Cancer Treat Rep; 1979 Jun; 63(6):951-60. PubMed ID: 466654
    [Abstract] [Full Text] [Related]

  • 9. [Pharmacokinetics of cisplatin and the effect of sodium thiosulfate].
    Hayata S, Hitoshi T, Kiyokawa K, Esaki S, Mihashi S, Hirano M.
    Gan To Kagaku Ryoho; 1984 Nov; 11(11):2356-61. PubMed ID: 6541891
    [Abstract] [Full Text] [Related]

  • 10. cis-Amminedichloro(2-methylpyridine) platinum(II) (AMD473), a novel sterically hindered platinum complex: in vivo activity, toxicology, and pharmacokinetics in mice.
    Raynaud FI, Boxall FE, Goddard PM, Valenti M, Jones M, Murrer BA, Abrams M, Kelland LR.
    Clin Cancer Res; 1997 Nov; 3(11):2063-74. PubMed ID: 9815598
    [Abstract] [Full Text] [Related]

  • 11. Effect of para-aminobenzoic acid on the pharmacokinetics and urinary excretion of cis-diamminedichloroplatinum(II) in rats.
    Esposito M, Vannozzi M, Viale M, Pellecchia C, Civalleri D, Gogioso L.
    Anticancer Res; 1995 Nov; 15(6B):2541-7. PubMed ID: 8669820
    [Abstract] [Full Text] [Related]

  • 12. Model independent pharmacokinetic study of cis-dichlorodiammineplatinum (II).
    Dumas M, d'Athis P, de Gislain C, Escousse A, Guerrin J, Autissier N.
    Int J Clin Pharmacol Ther Toxicol; 1985 Aug; 23(8):430-3. PubMed ID: 4044076
    [Abstract] [Full Text] [Related]

  • 13. Distribution and disposition of platinum following intravenous administration of cis-diamminedichloroplatinum(II) (NSC 119875) to dogs.
    Litterst CL, Gram TE, Dedrick RL, Leroy AF, Guarino AM.
    Cancer Res; 1976 Jul; 36(7 PT 1):2340-4. PubMed ID: 1277140
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Kinetics of platinum in cancer patients treated with cisplatin at different doses.
    Fracasso ME, Apostoli P, Benoni G, Bonetti A, Griso C, Leone R.
    Drugs Exp Clin Res; 1987 Jul; 13(6):367-72. PubMed ID: 3652926
    [Abstract] [Full Text] [Related]

  • 16. Pharmacokinetics of free and total platinum species after short-term infusion of cisplatin.
    Vermorken JB, van der Vijgh WJ, Klein I, Hart AA, Gall HE, Pinedo HM.
    Cancer Treat Rep; 1984 Mar; 68(3):505-13. PubMed ID: 6538459
    [Abstract] [Full Text] [Related]

  • 17. [Studies on the appropriate administration of cisplatin based on pharmacokinetics and toxicity].
    Kitajima K, Fukuoka M, Kobayashi S, Kusunoki Y, Takada M, Negoro S, Matsui K, Sakai N, Ryu S, Takifuji N.
    Gan To Kagaku Ryoho; 1987 Aug; 14(8):2517-23. PubMed ID: 3039920
    [Abstract] [Full Text] [Related]

  • 18. [Pharmacokinetics of plasma and cerebrospinal fluid cisplatin in patients with malignant glioma and metastatic brain tumor after selective intraarterial or intravenous and intracarotid administration of etoposide and cisplatin].
    Nakagawa H, Miyawaki Y, Tokiyoshi K, Tsuruzono K, Yamada M, Kanayama T, Hayakawa T.
    No Shinkei Geka; 1994 Jan; 22(1):35-42. PubMed ID: 8295700
    [Abstract] [Full Text] [Related]

  • 19. High-dose cisplatin therapy using mannitol versus furosemide diuresis: comparative pharmacokinetics and toxicity.
    Ostrow S, Egorin MJ, Hahn D, Markus S, Aisner J, Chang P, LeRoy A, Bachur NR, Wiernik PH.
    Cancer Treat Rep; 1981 Jan; 65(1-2):73-8. PubMed ID: 6784924
    [Abstract] [Full Text] [Related]

  • 20. High-dose cis-diamminedichloro-platinum therapy in patients with advanced breast cancer: pharmacokinetics, toxicity, and therapeutic efficacy.
    Ostrow S, Egorin M, Aisner J, Bachur N, Wiernik PH.
    Cancer Clin Trials; 1980 Jan; 3(1):23-7. PubMed ID: 7190082
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.